Manejo de pacientes con diagnóstico de adenoma hipofisario productor de prolactina. Experiencia del Hospital San José

Manejo de pacientes con diagnóstico de adenoma hipofisario productor de prolactina. Experiencia del Hospital San José

Introducción: El prolactinoma es el tumor hipofisiario funcionante más frecuente. Objetivo: Describir la experiencia del servicio de endocrinología del Hospital San José de Bogotá en el manejo de pacientes con prolactinoma que consultaron entre enero de 2006 y diciembre de 2012. Métodos: Serie de c...

Full description

Bibliographic Details
Main Authors:	Diana Cristina Henao, William Rojas
Format:	Article
Language:	English
Published:	Asociación Colombiana de Endocrinología 2017-03-01
Series:	Revista Colombiana de Endocrinología, Diabetes y Metabolismo
Subjects:	prolactinoma Hiperprolactinemia agonistas de dopamina cabergolina bromocriptina Hyperprolactinemia
Online Access:	https://revistaendocrino.org/index.php/rcedm/article/view/57

Similar Items

ACTUALIZACIÓN DE ENFOQUES DIAGNÓSTICOS Y TERAPÉUTICOS EN ADENOMAS HIPOFISIARIOS PRODUCTORES DE PROLACTINA: REVISIÓN NARRATIVA
by: Jhoanna Cristina Almeida Alvarado, et al.
Published: (2023-08-01)

Manejo exitoso de macroadenoma hipofisario no funcionante con cabergolina
by: J. G. Sarmiento, et al.
Published: (2020-09-01)

Prolactinomas may have unusual presentations resulting from massive extrasellar tumor extension
by: Marise Ribeiro de Sousa Berriel, et al.
Published: (2016-07-01)

Prolactinoma e hiperprolactinemia. Posicionamiento de la SMNE
by: Ernesto Sosa-Eroza, et al.
Published: (2023-01-01)

Respuesta clínica y bioquímica al manejo de macroprolactinomas en hombres latinoamericanos, Cali, Colombia y la Habana, Cuba
by: Alín Abreu-Lomba, et al.
Published: (2023-04-01)

Caracterización clínico-epidemiológica de pacientes con hiperprolactinemia y adenomas hipofisiarios productores de prolactina
by: Sofía Isea, et al.
Published: (2022-04-01)

Caracterización clínico-epidemiológica de pacientes con hiperprolactinemia y adenomas hipofisiarios productores de prolactina
by: Sofía Isea, et al.
Published: (2022-03-01)

Prolactinomas: ¿existe algún hallazgo en la RM al diagnóstico asociado con la resistencia a la cabergolina?
by: Jesús I. Castro-Murillo, et al.
Published: (2023-01-01)

Influência dos níveis de prolactina e tamanho tumoral na função hipofisária pós-operatória em macroadenomas hipofisários clinicamente não-funcionantes Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfuncioning pituitary macroadenomas
by: Ana Luiza Vidal Fonseca, et al.
Published: (2002-09-01)

Hipomanía inducida por cabergolina y quinagolida en un paciente conmacroadenoma hipofisario: reporte de un caso y revisión de la literatura
by: Genís F Fucho-Rius, et al.
Published: (2022-11-01)

Prolactinoma asociada a hiperaldosteronismo primario: ¿existe una relación entre ambas entidades?
by: María Carolina Fragozo-Ramos, et al.
Published: (2023-08-01)

Increased Lipid Levels Improves after Treatment with Cabergolin in Patients with Prolactinoma
by: Mazhar Muslum Tuna, et al.
Published: (2015-03-01)

Bromocriptina
by: Patricio Michaud C.
Published: (2017-07-01)

Agonistas dopaminérgicos para el tratamiento de microprolactinoma en pacientes con trastorno bipolar, a propósito de un caso.
by: Lucía Lafuente, et al.
Published: (2021-11-01)

Comparative efficacy and safety of generic (Bergolak) vs. brand cabergoline in the treatment of patients with prolactin-secreting tumors
by: Galina Afanas'evna Melnichenko, et al.
Published: (2015-04-01)

Hiperprolactinemia en psicosis tempranas: ¿secundaria a estrés o a una regulación alterada de la secreción de prolactina? .
by: J. Labad, et al.
Published: (2021-09-01)

Predicción del tamaño de prolactinomas mediante el valor plasmático de prolactina: la propuesta de una fórmula
by: Javier Calvo Marín, et al.
Published: (2017-03-01)

A clinical case of effective treatment of giant prolactinoma in patient with morbid obesity
Published: (2014-06-01)

Prolactinoma or leiomyoma-associated hyperprolactinemia—this is the question, a case report and review of the literature
by: Ralitsa Robeva, et al.
Published: (2022-09-01)

The efficacy of high-dose cabergoline treatment of prolactinomas resistant to standard doses: a clinical observation
by: Zilya A. Kalmykova, et al.
Published: (2019-09-01)

Endocrine disorders due to Rathke’s cleft cyst: a clinical case presentation
by: Svetlana Vorotnikova, et al.
Published: (2016-12-01)

Clinical features of hyperprolactinemia in children: modern methods of diagnosis and treatment
by: A.E. Abaturov, et al.
Published: (2022-03-01)

Enfermedad de Cushing en el embarazo y uso de cabergolina
by: Natacha Belén Murillo, et al.
Published: (2023-03-01)

Clinical guidelines ‘Hyperprolactinemia’ (draft)
by: I. I. Dedov, et al.
Published: (2023-07-01)

Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else
by: Anna Cho, et al.
Published: (2022-09-01)

Metabolic effects of prolactin and the role of dopamine agonists: A review
by: Polly Kirsch, et al.
Published: (2022-09-01)

The efficacy and safety of quinagolide in hyperprolactinemia treatment: A systematic review and meta-analysis
by: Yanyang Zeng, et al.
Published: (2023-01-01)

Current and Perspective Approaches to the Treatment of Prolactinomas
by: Nadiya Barabash, et al.
Published: (2023-07-01)

Pituitary adenoma with hypothalamic involvement: a case of ‘atypical’ atypical depression
by: Manjunadh Muraleedharan, et al.
Published: (2018-07-01)

Gigantomastia gestacional: relato de caso e revisão bibliográfica
by: Mário Rogério da Silva Santos, et al.
Published: (2011-09-01)

Interpretation of the 2022 ICCE/AME Position Statement for Clinical Practice in Pituitary Prolactinoma: Update on Clinical Characteristics and Points of Diagnosis and Treatment of Pituitary Prolactinoma
by: TAN Huiwen, LI Danting, YU Yerong
Published: (2024-02-01)

Infertility after long-acting paliperidone palmitate treatment: A case report (tur)
by: Kerim Uğur, et al.
Published: (2020-04-01)

Granulomatous mastitis (GM) in a young woman with a previous history of prolactin-secreting PitNET and actual normal prolactinemia
by: Cristiana Boldrini, MD
Published: (2023-02-01)

Síndrome de hiperestimulación ovárica como manifestación de adenoma hipofisario gigante productor de FSH
by: Ma. Fernanda Armenta-Manjarrez, et al.
Published: (2023-01-01)

Mudança no padrão biológico da migrânea com aura após a utilização da tetrabenazina: relato de caso
by: ELCIO JULIATO PIOVESAN, et al.
Published: (2000-06-01)

Síndrome neuroléptico maligno asociado con intoxicación aguda por un organofosforado: reporte de caso
by: Nancy Y. Angulo, et al.
Published: (2022-09-01)

Thyroid autoimmunity and subclinical hypothyroidism in prolactinoma: A case control study
by: Bashir A Laway, et al.
Published: (2023-01-01)

Caracterización clínico-etiológica y bioquímica de pacientes con ginecomastia
by: Dania Jiménez Almaguer, et al.
Published: (2020-08-01)

Síndrome de piernas inquietas. Enfoque diagnóstico y tratamiento
by: María Isabel Montes Gaviria.
Published: (2023-07-01)

Síndrome de piernas inquietas. Enfoque diagnóstico y tratamiento
by: María Isabel Montes Gaviria.
Published: (2023-07-01)